These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 776916)

  • 1. C-2801X, a new cephamycin-type antibiotic II. Isolation and characterization.
    Fukase H; Hasegawa T; Hatano K; Iwasaki H; Yoneda M
    J Antibiot (Tokyo); 1976 Feb; 29(2):113-20. PubMed ID: 776916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New producer of cephamycin C, Streptomyces filipinensis var. cephamycini var. nov].
    Gauze GF; Chugasova VA; Terekhova LP; Lomakina NN; Fedorova GB
    Antibiotiki; 1976 Dec; 21(12):1059-62. PubMed ID: 1020936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cefotetan, a new cephamycin antibiotic: in vitro and in vivo antibacterial activities (author's transl)].
    Yano K; Suzaki K; Saito M; Toda M; Naito S; Ohmi Y
    Jpn J Antibiot; 1982 Feb; 35(2):438-59. PubMed ID: 6953260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery, isolation and structure of novel cephamycins of Streptomyces chartreusis.
    Inouye S; Kojima M; Shomura T; Iwamatsu K; Niwa T; Kondo Y; Niida T; Ogawa Y; Kusama K
    J Antibiot (Tokyo); 1983 Feb; 36(2):115-24. PubMed ID: 6833126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oganomycin A, a new cephamycin-type antibiotic produced by Streptomyces oganonensis and its derivatives, oganomycins B, GA and GB.
    Gushima H; Watanabe S; Saito T; Sasaki T; Eiki H; Oka Y; Osono T
    J Antibiot (Tokyo); 1981 Nov; 34(11):1507-12. PubMed ID: 7319912
    [No Abstract]   [Full Text] [Related]  

  • 6. Cephamycin derivatives: comparison of the in vitro and in vivo antibacterial activities of SQ 14,359, CS-1170, and cefoxitin.
    Gadebusch HH; Schwind R; Lukaszow P; Whitney R; McRipley RJ
    J Antibiot (Tokyo); 1978 Oct; 31(10):1046-58. PubMed ID: 711611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of indicators for cephamycin bioassay.
    Rani S; Sarada I; Sircar A; Sridhar P
    Indian J Exp Biol; 1996 Aug; 34(8):816-7. PubMed ID: 8979493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and chemotherapeutic studies on three semisynthetic cephamycins.
    Uri JV; Actor P; Guarini JR; Phillips L; Pitkin D; Demarinis RM; Weisbach JA
    J Antibiot (Tokyo); 1978 Jan; 31(1):82-91. PubMed ID: 627526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosynthesis of a 7-alpha-methoxycephalosporin. Incorporation of molecular oxygen.
    O'Sullivan J; Aplin RT; Stevens CM; Abraham EP
    Biochem J; 1979 Apr; 179(1):47-52. PubMed ID: 475760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of cephamycin C in fermentation broths by means of thin-layer spectrodensitometry.
    Treiber LR
    J Chromatogr; 1981 Aug; 213(1):129-36. PubMed ID: 7287849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on auromomycin.
    Yamashita T; Naoi N; Hidaka T; Watanabe K; Kumada Y; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1979 Apr; 32(4):330-9. PubMed ID: 468720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary investigation of the structure of antibiotics produced by highly active mutants of Streptomyces griseus NRRL 3851 and Streptomyces lactamdurans NRRL 3802.
    Malina HZ; Grudziński SK; Zalega UD
    Acta Microbiol Pol; 1984; 33(3-4):227-37. PubMed ID: 6083707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cephamycins, a new family of beta-lactam antibiotics. II. Isolation and chemical characterization.
    Miller TW; Goegelman RT; Weston RG; Putter I; Wolf FJ
    Antimicrob Agents Chemother; 1972 Sep; 2(3):132-5. PubMed ID: 4790553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Holomycin and N-propionylholothin, antibiotics produced by a cephamycin C producer.
    Okamura K; Soga K; Shimauchi Y; Ishikura T; Lein J
    J Antibiot (Tokyo); 1977 Apr; 30(4):334-6. PubMed ID: 863793
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical value of cefmetazole and other cephamycin antibiotics].
    Simada D
    Antibiot Khimioter; 1995 Jan; 40(1):13-21. PubMed ID: 7605125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fundamental and clinical studies on T-1982 (cefbuperzone), a new cephamycin antibiotic, in the field of pediatrics].
    Nakazawa S; Sato H; Niino K; Hirama Y; Narita A; Suzuki H; Nakazawa S; Chikaoka H; Tazoe K; Irino Y; Nakada Y; Yoshihara T
    Jpn J Antibiot; 1983 Apr; 36(4):771-89. PubMed ID: 6308296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cephamycins, a new family of beta-lactam antibiotics. IV. In vivo studies.
    Miller AK; Celozzi E; Kong Y; Pelak BA; Kropp H; Stapley EO; Hendlin D
    Antimicrob Agents Chemother; 1972 Oct; 2(4):287-90. PubMed ID: 4670502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A35512, a complex of new antibacterial antibiotics produced by Streptomyces candidus. I. Isolation and characterization.
    Michel KH; Shah RM; Hamill RL
    J Antibiot (Tokyo); 1980 Dec; 33(12):1397-406. PubMed ID: 7251482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic study on cephamycin C degradation.
    Brites LM; Oliveira LM; Barboza M
    Appl Biochem Biotechnol; 2013 Dec; 171(8):2121-8. PubMed ID: 24026415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical studies of T-1982 (cefbuperazone) in the field of pediatrics].
    Watanabe N; Kida K; Matsuda H; Murase M; Ishikawa J; Ichinomiya M
    Jpn J Antibiot; 1983 Apr; 36(4):881-7. PubMed ID: 6348342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.